News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
Cidara Therapeutics and Melinta Therapeutics Announce FDA Advisory Committee Recommends Approval of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
Cidara Therapeutics and Melinta Therapeutics Announce FDA Advisory Committee Recommends Approval of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
January 24, 2023 Press Release FDA decision expected by PDUFA target action date of March 22, 2023 If approved, rezafungin will be the first new drug for the treatment of candidemia and invasive
The Antimicrobials Working Group Announces Appointment of Christine Ann Miller as Board Chair
The Antimicrobials Working Group Announces Appointment of Christine Ann Miller as Board Chair
January 17, 2023 Press Release WASHINGTON, Jan. 17, 2023 /PRNewswire/ -- The Antimicrobials Working Group (AWG), an industry-led coalition of antimicrobial companies, announced today the
Melinta Therapeutics & OptimizeRx Announce 2022 Innovate4Outcomes Event
Melinta Therapeutics & OptimizeRx Announce 2022 Innovate4Outcomes Event
November 28, 2022 Press Release Competition To Focus On Improving Diverse Patients’ Access to Treatment And Responses to Treatment for Antimicrobial Resistance PARSIPPANY, N.J.–Melinta